Avanos Medical Inc (AVNS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.65 is considered Undervalued compared with the five-year average of 17.40. The fair price of Avanos Medical Inc (AVNS) is between 16.41 to 28.58 according to relative valuation method. Compared to the current price of 13.98 USD , Avanos Medical Inc By Undervalued By 14.82%.

Relative Value

Fair Zone

16.41-28.58

Current Price：13.98

14.82%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Avanos Medical Inc (AVNS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Avanos Medical Inc (AVNS) has a current Price-to-Book (P/B) ratio of 0.67. Compared to its 3-year average P/B ratio of 0.77, the current P/B ratio is approximately -13.20% higher. Relative to its 5-year average P/B ratio of 0.94, the current P/B ratio is about -29.30% higher. Avanos Medical Inc (AVNS) has a Forward Free Cash Flow (FCF) yield of approximately 14.43%. Compared to its 3-year average FCF yield of 7.35%, the current FCF yield is approximately 96.24% lower. Relative to its 5-year average FCF yield of 5.77%, the current FCF yield is about 150.34% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for AVNS competitors is 169.50, providing a benchmark for relative valuation. Avanos Medical Inc Corp (AVNS.N) exhibits a P/S ratio of 0.74, which is -99.56% above the industry average. Given its robust revenue growth of 0.72%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of AVNS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of AVNS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is AVNS currently overvalued or undervalued?

What is Avanos Medical Inc (AVNS) fair value?

AVNS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Avanos Medical Inc (AVNS) is between 16.41 to 28.58 according to relative valuation method.

How does AVNS's valuation metrics compare to the industry average?

The average P/S ratio for AVNS's competitors is 169.50, providing a benchmark for relative valuation. Avanos Medical Inc Corp (AVNS) exhibits a P/S ratio of 0.74, which is -99.56% above the industry average. Given its robust revenue growth of 0.72%, this premium appears unsustainable.

What is the current P/B ratio for Avanos Medical Inc (AVNS) as of Mar 03 2026?

As of Mar 03 2026, Avanos Medical Inc (AVNS) has a P/B ratio of 0.67. This indicates that the market values AVNS at 0.67 times its book value.

What is the current FCF Yield for Avanos Medical Inc (AVNS) as of Mar 03 2026?

As of Mar 03 2026, Avanos Medical Inc (AVNS) has a FCF Yield of 14.43%. This means that for every dollar of Avanos Medical Inc's market capitalization, the company generates 14.43 cents in free cash flow.

What is the current Forward P/E ratio for Avanos Medical Inc (AVNS) as of Mar 03 2026?

As of Mar 03 2026, Avanos Medical Inc (AVNS) has a Forward P/E ratio of 11.65. This means the market is willing to pay $11.65 for every dollar of Avanos Medical Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Avanos Medical Inc (AVNS) as of Mar 03 2026?

As of Mar 03 2026, Avanos Medical Inc (AVNS) has a Forward P/S ratio of 0.74. This means the market is valuing AVNS at $0.74 for every dollar of expected revenue over the next 12 months.

AVNS Valuation